BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: El Bairi K, Amrani M, Kandhro AH, Afqir S. Prediction of therapy response in ovarian cancer: Where are we now? Critical Reviews in Clinical Laboratory Sciences 2017;54:233-66. [DOI: 10.1080/10408363.2017.1313190] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 4.8] [Reference Citation Analysis]
Number Citing Articles
1 Li X, Zhang H, Huo Y. High HOXA9 gene expression predicts response to chemotherapy and prognosis of high-grade serous ovarian cancer patients. J Int Med Res 2022;50:030006052211358. [DOI: 10.1177/03000605221135864] [Reference Citation Analysis]
2 Gunderson CC, Radhakrishnan R, Gomathinayagam R, Husain S, Aravindan S, Moore KM, Dhanasekaran DN, Jayaraman M. Circulating Tumor Cell-Free DNA Genes as Prognostic Gene Signature for Platinum Resistant Ovarian Cancer Diagnosis. Biomark�Insights 2022;17:117727192210884. [DOI: 10.1177/11772719221088404] [Reference Citation Analysis]
3 Wang Z, Yang B. Polypharmacology in Old Drug Rediscovery: Drug Repurposing. Polypharmacology 2022. [DOI: 10.1007/978-3-031-04998-9_13] [Reference Citation Analysis]
4 Bairi KE, Trapani D, Page CL, Saad A, Jarroudi OA, Afqir S. Exploring the prognostic impact of tumor sidedness in ovarian cancer: A population-based survival analysis of over 10,000 patients. Cancer Treatment and Research Communications 2022;33:100625. [DOI: 10.1016/j.ctarc.2022.100625] [Reference Citation Analysis]
5 Jabi R, Elmir S, El Arabi S, Merry A, Bouziane M. Rectorrhagia revealing colonic metastasis from an ovarian primary, an exceptional case report. Int J Surg Case Rep 2021;88:106490. [PMID: 34710771 DOI: 10.1016/j.ijscr.2021.106490] [Reference Citation Analysis]
6 El Bairi K, Al Jarroudi O, Afqir S. Ovarian cancer in Morocco: Time to act is now. Gynecol Oncol Rep 2021;37:100857. [PMID: 34541276 DOI: 10.1016/j.gore.2021.100857] [Reference Citation Analysis]
7 Dowarah J, Marak BN, Yadav UCS, Singh VP. Potential drug development and therapeutic approaches for clinical intervention in COVID-19. Bioorg Chem 2021;114:105016. [PMID: 34144277 DOI: 10.1016/j.bioorg.2021.105016] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
8 Bocharova EA, Kopytina NI, Slynko ЕЕ. Anti-tumour drugs of marine origin currently at various stages of clinical trials (review). Regul Mech Biosyst 2021;12:265-80. [DOI: 10.15421/022136] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
9 El Bairi K, Al Jarroudi O, Afqir S. Tracing ovarian cancer research in Morocco: A bibliometric analysis. Gynecol Oncol Rep 2021;37:100777. [PMID: 34150972 DOI: 10.1016/j.gore.2021.100777] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 El Bairi K, Al Jarroudi O, Afqir S. Revisiting antibody-drug conjugates and their predictive biomarkers in platinum-resistant ovarian cancer. Semin Cancer Biol 2021:S1044-579X(21)00081-X. [PMID: 33812984 DOI: 10.1016/j.semcancer.2021.03.031] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
11 Wang K, Wang Y, Wang Y, Liu S, Wang C, Zhang S, Zhang T, Yang X. EIF5A2 enhances stemness of epithelial ovarian cancer cells via a E2F1/KLF4 axis. Stem Cell Res Ther 2021;12:186. [PMID: 33726845 DOI: 10.1186/s13287-021-02256-2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
12 El Bairi K, Al Jarroudi O, Carpenito L, Trapani D, Afqir S. The Advent of Circulating Tumor DNA in the Management of Ovarian Cancer. Ovarian Cancer Biomarkers 2021. [DOI: 10.1007/978-981-16-1873-4_5] [Reference Citation Analysis]
13 El Bairi K, Trapani D, Petrillo A, Le Page C, Zbakh H, Daniele B, Belbaraka R, Curigliano G, Afqir S. Repurposing anticancer drugs for the management of COVID-19. Eur J Cancer 2020;141:40-61. [PMID: 33125946 DOI: 10.1016/j.ejca.2020.09.014] [Cited by in Crossref: 43] [Cited by in F6Publishing: 45] [Article Influence: 21.5] [Reference Citation Analysis]
14 Pang HF, Li XX, Zhao YH, Kang JK, Li JY, Tian W, Wang CM, Hou HX, Li DR. Confirming whether novel rhein derivative 4a induces paraptosis-like cell death by endoplasmic reticulum stress in ovarian cancer cells. Eur J Pharmacol 2020;886:173526. [PMID: 32890460 DOI: 10.1016/j.ejphar.2020.173526] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
15 El Bairi K, Jabi R, Trapani D, Boutallaka H, Ouled Amar Bencheikh B, Bouziane M, Amrani M, Afqir S, Maleb A. Can the microbiota predict response to systemic cancer therapy, surgical outcomes, and survival? The answer is in the gut. Expert Rev Clin Pharmacol 2020;13:403-21. [PMID: 32308061 DOI: 10.1080/17512433.2020.1758063] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
16 Lin G, Zhao R, Wang Y, Han J, Gu Y, Pan Y, Ren C, Ren S, Xu C. Dynamic analysis of N-glycomic and transcriptomic changes in the development of ovarian cancer cell line A2780 to its three cisplatin-resistant variants. Ann Transl Med 2020;8:289. [PMID: 32355733 DOI: 10.21037/atm.2020.03.12] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
17 El Bairi K, Lengyel C, Marra A, Afqir S. Colorectal Cancer Genetics: An Overview of the Actionable Building Blocks. Illuminating Colorectal Cancer Genomics by Next-Generation Sequencing 2020. [DOI: 10.1007/978-3-030-53821-7_2] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
18 Tonozzi TR, Kammesheidt A, Braunstein GD, Independent researcher, Independent researcher, Department of Medicine, Cedars-Sinai Medical Center Los Angeles, California, USA. Liquid Biopsies in Endocrine Neoplasia—A Systematic Review. US Endocrinology 2019;15:39. [DOI: 10.17925/use.2019.15.1.39] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
19 Noye TM, Lokman NA, Oehler MK, Ricciardelli C. S100A10 and Cancer Hallmarks: Structure, Functions, and its Emerging Role in Ovarian Cancer. Int J Mol Sci 2018;19:E4122. [PMID: 30572596 DOI: 10.3390/ijms19124122] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 6.3] [Reference Citation Analysis]
20 Xu Y, Zhang Q, Miao C, Dongol S, Li Y, Jin C, Dong R, Li Y, Yang X, Kong B. CCNG1 (Cyclin G1) regulation by mutant-P53 via induction of Notch3 expression promotes high-grade serous ovarian cancer (HGSOC) tumorigenesis and progression. Cancer Med 2019;8:351-62. [PMID: 30565428 DOI: 10.1002/cam4.1812] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 4.0] [Reference Citation Analysis]
21 El Bairi K, Atanasov AG, Amrani M, Afqir S. The arrival of predictive biomarkers for monitoring therapy response to natural compounds in cancer drug discovery. Biomed Pharmacother 2019;109:2492-8. [PMID: 30551510 DOI: 10.1016/j.biopha.2018.11.097] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 4.0] [Reference Citation Analysis]
22 El Bairi K, Amrani M, Afqir S. Starvation tactics using natural compounds for advanced cancers: pharmacodynamics, clinical efficacy, and predictive biomarkers. Cancer Med 2018;7:2221-46. [PMID: 29732738 DOI: 10.1002/cam4.1467] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
23 Xue J, Li R, Zhao X, Ma C, Lv X, Liu L, Liu P. Morusin induces paraptosis-like cell death through mitochondrial calcium overload and dysfunction in epithelial ovarian cancer. Chem Biol Interact 2018;283:59-74. [PMID: 29421517 DOI: 10.1016/j.cbi.2018.02.003] [Cited by in Crossref: 46] [Cited by in F6Publishing: 47] [Article Influence: 11.5] [Reference Citation Analysis]
24 El Bairi K, Tariq K, Himri I, Jaafari A, Smaili W, Kandhro AH, Gouri A, Ghazi B. Decoding colorectal cancer epigenomics. Cancer Genet 2018;220:49-76. [PMID: 29310839 DOI: 10.1016/j.cancergen.2017.11.001] [Cited by in Crossref: 33] [Cited by in F6Publishing: 36] [Article Influence: 6.6] [Reference Citation Analysis]